Skip to content

Clinical trials

Completed Lymphoma, T-Cell, Cutaneous trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Status: Completed Clear all

314 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200018
200111
200215
200323
200419
200523
200616
200721
200815
20099
201014
201112
201210
20136
20144
20157
20167
20177
20184
20192
20203
20215
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed314

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)42
Fred Hutchinson Cancer Center29
Memorial Sloan Kettering Cancer Center13
Case Comprehensive Cancer Center11
National Institutes of Health Clinical Center (CC)11
Northwestern University11
City of Hope Medical Center9
Roswell Park Cancer Institute8
Mayo Clinic7
Wake Forest University Health Sciences6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous314
Mycosis Fungoides223
Sezary Syndrome215
Leukemia, Lymphocytic, Chronic, B-Cell192
Lymphoma, Follicular188
Lymphoma, Large B-Cell, Diffuse186
Lymphoma, Non-Hodgkin186
Lymphoma, B-Cell, Marginal Zone185
Precursor Cell Lymphoblastic Leukemia-Lymphoma185
Lymphoma, Mantle-Cell183

Trials

Showing 1 to 25 of 314. Each trial links to its page on Pharma Observatory.

214 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.